跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FINTEPLA 2,2 mg/ml SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FINTEPLA 2,2 mg/ml SOLUCION ORAL
Approved
STANDARD
FINTEPLA 2,2 mg/ml SOLUCION ORAL
Ucb Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 2, 2021
Approval ID
a6a10988a5c9526b
Company
Ucb Pharma
Type
Standard
Approval Details
Approval Id
a6a10988a5c9526b
Drug Cima Aemps Name
FINTEPLA 2,2 mg/ml SOLUCION ORAL
Register Number
1201491001
Holder Company Name
Ucb Pharma
Marketing Company Name
Ucb Pharma S.A.
Holder Company Detail Path
/organization/ucb-pharma-sa
Marketing Company Detail Path
/organization/ucb-pharma-sa-switzerland
Authorization Date
2021-06-02
Dosage Form
SOLUCIÓN ORAL
Dose
2.2 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Ucb Pharma
Company Detail Path
/organization/ucb-pharma-sa
Company Information
Pharmaceutical Company Name
UCB S.A.
Name En
UCB S.A.
Country Name
Belgium
City Name
Brussels
Address
Brussels, Belgium
Website
https://www.ucb.com
Active Ingredients
FENFLURAMINA HIDROCLORURO
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 2, 2021
Approval ID
a6a10988a5c9526b
Type
Standard
Back to CIMA-AEMPS Approvals